NCT03272633 2023-06-26
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Terminated
Clinical Trials
4 trialsNCT03173430 2020-02-07
Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT00470093 2018-11-16
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT01537861 2015-01-26
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Washington University School of Medicine
Phase EARLY_PHASE1 Terminated